About us

As the global leader in implantable hearing solutions, we have provided more than 750,000 implantable devices – more than any other company – helping people of all ages to hear and connect with life’s opportunities.

Our mission

We help people hear and be heard.

We empower people to connect with others and live a full life.

We help transform the way people understand and treat hearing loss.

We innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.*

Acknowledgement of Country

Worimi (‘hello’ in local Darug language). Cochlear’s headquarters are located on the unceded lands of the Wattamatagal Peoples of the Darug Nation. Cochlear is committed to reconciliation. Learn more about our Reconciliation Action Plan. Illustration credit: ‘Joy of Sound’ by Balarinji.

Learn more

Proven over time

From Professor Graeme Clark’s discovery with a shell and a blade of grass through to today, we remain committed to advancing hearing technology.

Driving progress

You inspire our passion for progress. To meet your needs now and into the future, we continue to innovate and pioneer new technology.

Connecting the community

People choose Cochlear to join the world’s largest community with hearing implants, supported by a network of carers and hearing professionals.

Disclaimer

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

*"A lifetime of hearing performance” and similar phrases should not be understood as claims relating to the expected life, reliability, quality or performance of Cochlear’s products.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

Any testimonial featured on this website is intended for an Australian audience only.